Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Epidemiology

Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds

Alison P. Klein, Kieran A. Brune, Gloria M. Petersen, Michael Goggins, Anne C. Tersmette, G. Johan A. Offerhaus, Constance Griffin, John L. Cameron, Charles J. Yeo, Scott Kern and Ralph H. Hruban
Alison P. Klein
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kieran A. Brune
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gloria M. Petersen
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Goggins
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne C. Tersmette
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Johan A. Offerhaus
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constance Griffin
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Cameron
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles J. Yeo
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Kern
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph H. Hruban
1Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland; 2 Departments of Pathology, 3 Oncology, and 4 Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland; 5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; and 6Department of Pathology, the Academic Medical Center, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.CAN-03-3823 Published April 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1

    Mean age at baseline of at-risk family members and age at diagnosis of pancreatic cancer among incident cases in families

    At-risk family membersProspective cases
    No. of individualsaAge at baseline (±SD)No. of individualsAge at diagnosis of pancreatic cancer (±SD)b
    FPCc
     Male114152.5 (± 18.2)769.5 (± 8.5)
     Female133054.3 (± 18.7)868.4 (± 14.3)
    SPC
     Male107252.5 (± 18.7)359.4 (± 9.7)
     Female129355.7 (± 19.2)0nac
    Unrelated
     Male13566.8 (± 10.7)1>65
     Female23463.0 (± 11.9)0na
    Totala517954.6 (± 18.6)19
    • a Because of changes in family cancer status over time, the sum of the number of individuals in each stratum is not equal to the total number of individuals in the study.

    • b To protect the confidentiality of the participants only mean ages (when >2 cases) or age group data (≤2 cases) are shown and the mean (SD) of all cases is not presented.

    • c FPC, familial pancreatic cancer; SPC, sporadic pancreatic cancer; na, not applicable.

  • Table 2

    Risk of pancreatic cancer among unrelated family members and among individuals with a first-degree relative with pancreatic cancer in the familial (FPC) kindreds and sporadic (SPC) kindreds

    Family statusaNo. of individualsPerson-years of follow-upObserved casesExpected casesbSIRc (95% CI)
    FPC Kindreds19935273111.229.0 (4.5–16.1)
    SPC Kindreds1964526521.121.8 (0.22–6.42)
    Unrelated369107310.412.4 (0.06–13.5)
    • a FPC kindreds were defined as kindreds having at least one pair of first-degree relatives with pancreatic cancer, and SPC kindreds as families without such an affected pair.

    • b Adjusted for age, sex, and race.

    • c SIR, standardized incidence ratio; CI, confidence interval.

  • Table 3

    Risk of pancreatic cancer (PC) among members of familial pancreatic cancer (FPC) kindreds stratified by their number of first-degree relatives (FDRs) with pancreatic cancer

    No. of FDRs with PCaNo. of individualsPerson-years of follow-upObserved casesExpected casesbSIRc (95% CI)
    3 or more106287.250.15632.0 (10.4–74.7)
    26341597.940.6236.4 (1.8–16.4)
    112533388.020.4424.5 (0.54–16.3)
    • a Denotes each individual’s number of FDRs with pancreatic cancer (i.e., the number of their parents, siblings, and children with pancreatic cancer).

    • b Adjusted for age, sex, and race.

    • c SIR, standardized incidence ratio; CI, confidence interval.

  • Table 4

    Standardized incidence ratios (SIRs) for pancreatic cancer in members of kindreds with at least one first-degree relative with pancreatic cancer by smoking status and age

    No. of individualsaPerson-years of follow-upObserved casesExpected casesSIR (95% CI)b
    Smoking status
     Ever smoker546176170.36519.2 (7.7–39.5)
     Never smoker1214294140.6406.25 (1.70–16.0)
     Unknown23357200.2140 (0–17.3)
    Age
     <45738173900.0200 (0–615)
     45–64.9833203340.25315.8 (4.31–40.4)
     ≥65620150270.9477.4 (2.97–15.2)
    • a Because of changes in age strata during follow-up, numbers do not equal total number of individuals in study.

    • b CI, confidence interval.

  • Table 5

    Estimated incidence of pancreatic cancer in the general United States (U.S.) population among familial pancreatic cancer kindred members with at least one first-degree relative (FDR) with pancreatic cancer

    No. of FDRs with pancreatic cancerIncidence (per 100,000) in the general U.S. populationa
    3 or more288
    258
    141
    1 or more81
    General U.S. (reference)9
    • a SIR × incidence of pancreatic cancer in the general U.S. population.

PreviousNext
Back to top
Cancer Research: 64 (7)
April 2004
Volume 64, Issue 7
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Alison P. Klein, Kieran A. Brune, Gloria M. Petersen, Michael Goggins, Anne C. Tersmette, G. Johan A. Offerhaus, Constance Griffin, John L. Cameron, Charles J. Yeo, Scott Kern and Ralph H. Hruban
Cancer Res April 1 2004 (64) (7) 2634-2638; DOI: 10.1158/0008-5472.CAN-03-3823

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Alison P. Klein, Kieran A. Brune, Gloria M. Petersen, Michael Goggins, Anne C. Tersmette, G. Johan A. Offerhaus, Constance Griffin, John L. Cameron, Charles J. Yeo, Scott Kern and Ralph H. Hruban
Cancer Res April 1 2004 (64) (7) 2634-2638; DOI: 10.1158/0008-5472.CAN-03-3823
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Abstract 4634: Breastfeeding and prognosis of breast cancer among Chinese women
  • Abstract 6483: Performance characteristics of the first FDA-cleared droplet digital PCR (ddPCR) IVD assay for monitoring chronic myelogenous leukemia
  • Abstract 6495: Development of robust and reproducible controls to support clinical implementation of quantitative immunofluorescence assays for pharmacodynamic biomarkers
Show more Epidemiology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement